Copyright
©The Author(s) 2018.
World J Gastrointest Endosc. Sep 16, 2018; 10(9): 200-209
Published online Sep 16, 2018. doi: 10.4253/wjge.v10.i9.200
Published online Sep 16, 2018. doi: 10.4253/wjge.v10.i9.200
Table 1 Elixhauser comorbidity variables
| Comorbidity variables |
| Paralysis |
| Other neurological disordersl |
| Chronic pulmonary disease |
| Diabetes without chronic complications |
| Diabetes with chronic complications |
| Hypothyroidism |
| Renal failure |
| Liver disease |
| Chronic peptic ulcer disease |
| Human Immunodeficiency Virus or Acquired Immunodeficiency Syndrome |
| Lymphoma |
| Metastatic cancer |
| Solid tumor without metastasis |
| Rheumatoid arthritis/collagen vascular diseases |
| Coagulation deficiency |
| Obesity |
| Weight loss |
| Fluid and electrolyte disorders |
| Blood loss anemia |
| Deficiency anemias |
| Alcohol abuse |
| Drug abuse |
| Psychosis |
| Depression |
| Congestive heart failure |
| Valvular disease |
| Pulmonary circulation disorder |
| Peripheral vascular disorder |
| Hypertension |
Table 2 Patient and hospital characteristics of admissions for the primary diagnosis of gastroparesis (n = 30064), stratified by readmission status, National Readmission Database, 2010-2014
| Patient characteristics | 30-d readmission | ||
| Non (%)22007 (73.2%) | Yesn (%)8057 (26.8%) | P | |
| Age, mean (SD), yr | 50.1 (17.2) | 48 (16.3) | < 0.0001 |
| Age category, n (%) | < 0.0001 | ||
| 18-44 yr | 8766 (39.8) | 3658 (45.4) | |
| > 45 yr | 13241 (60.2) | 4399 (54.6) | |
| Sex, n (%) | 0.1590 | ||
| Male | 5625 (25.6) | 2124 (26.4) | |
| Female | 16382 (74.4) | 5933 (73.6) | |
| Length of stay in days, mean (SD) | 4.8 (5.2) | 5.6 (6.0) | < 0.0001 |
| Length of stay > 5 d | 5843 (26.6) | 2734 (33.9) | < 0.0001 |
| Diabetes | 4610 (20.9) | 1998 (24.8) | < 0.0001 |
| Diabetic ketoacidosis | 161 (0.7) | 73 (0.9) | 0.1270 |
| Enteral feeding tube placement | 704 (3.2) | 293 (3.6) | 0.0605 |
| Jejunostomy | 445 (2.0) | 168 (2.1) | |
| Gastrostomy | 185 (0.8) | 84 (1.0) | |
| Both jejunostomy and gastrostomy | 74 (0.3) | 41 (0.5) | |
| Gastric surgery | 495 (2.2) | 97 (1.2) | < 0.0001 |
| Partial gastrectomy | 231 (1.0) | 54 (0.7) | |
| Pyloroplasty | 223 ( 1.0) | 32 (0.4) | |
| Other (total gastrectomy, pyloromyotomy) | 41 (0.2) | 11 (0.1) | |
| Total parenteral nutrition | 753 (3.4) | 380 (4.7) | < 0.0001 |
| Number of Elixhauser comorbidities | < 0.0001 | ||
| < 4 | 14302 (65.0) | 4562 (56.6) | |
| ≥ 4 | 7705 (35.0) | 3495 (43.4) | |
| Elixhauser readmission index | 17.6 (13.7) | 21.3 (14.6) | < 0.0001 |
| mean (SD) | |||
| Total cost for index admission | $10502/$7573 | $13126/$7760 | < 0.0001 |
| mean/median (IQR) | ($4880-$11858) | ($4810-$13750) | |
| Primary payer, n (%)1 | < 0.0001 | ||
| Medicare | 8855 (40.3) | 3335 (41.5) | |
| Medicaid | 3770 (17.2) | 1811 (22.5) | |
| Private | 7039 (32.1) | 2108 (26.2) | |
| Self-pay, no charge, other | 2285 (10.4) | 787 (0.8) | |
| Income quartiles n (%)2 | 0.1100 | ||
| 1st quartile | 6968 (32.2) | 2636 (33.3) | |
| 2nd quartile | 5668 (26.2) | 2023 (25.5) | |
| 3rd quartile | 5029 (23.2) | 1882 (23.7) | |
| 4th quartile | 3970 (18.3) | 1386 (7.5) | |
| Discharge disposition, n (%)3 | < 0.0001 | ||
| Discharged home (routine discharge) | 18041 (82.0) | 6217 (77.2) | |
| Transfer: Short-term hospital | 113 (0.5) | 45 (0.6) | |
| Transfer: Other type of facility | 1184 (5.4) | 393 (4.9) | |
| Home health care | 2236 (10.2) | 1186 (14.7) | |
| Against medical advice | 431 (2.0) | 216 (2.7) | |
| Hospital characteristics | |||
| Hospital control, n (%) | 0.0460 | ||
| Government nonfederal | 3014 (13.7) | 1070 (13.3) | |
| Private (not-for-profit) | 14523 (66.0) | 5247 (65.1) | |
| Private investor owned | 4470 (20.3) | 1740 (21.6) | |
| Bed size, n (%) | 0.0070 | ||
| Small | 2115 (9.6) | 692 (8.6) | |
| Medium | 5577 (25.3) | 1993 (24.7) | |
| Large | 14315 (65.0) | 5372 (66.7) | |
| Teaching status, n (%) | < 0.0001 | ||
| Metropolitan non-teaching | 9204 (41.8) | 3379 (41.9) | |
| Metropolitan teaching | 10975 (49.9) | 4161 (51.6) | |
| Non-metropolitan | 1828 (8.3) | 517 (6.4) | |
Table 3 Summary of 30 and 90-d readmissions, underestimation of readmissions, and fragmentation of care in patients hospitalized with gastroparesis, National Readmission Database, 2010-2014
| Time | % Readmission (No/total No) | % Underestimation of readmission (No/total No) | % Fragmentation of care (No/total No.) |
| 30-d | 26.8% (8057/30064) | 22% (1769/8057) | 28.1%(2260/ 8057) |
| 90-d | 45.6% (11987/26284) | 19.5%( 2334/11987) | 33.8%( 4049/11987) |
Table 4 Association of admission to a non-index hospital during the first readmission (care fragmentation) with in-hospital costs, length of stay, mortality, and 60-d readmission
| 30-d first readmission | ||||
| Readmission to index hospital | Readmission to non-index hospital | Comparison | P | |
| Total cost for first readmission, mean/median (IQR) | $12311/$7508 | $15645/$8598 | Difference in cost: 3803$ (2777-4829)1 | < 0.0001 |
| ($4659-$13204) | ($5281-$15472) | |||
| Length of stay in days, mean (SD) | 5.8 (6.5) | 6.5 (8.2) | Adjusted HR (95%CI): 1.07 (1.01-1.13)2 | 0.03 |
| In-hospital Mortality | 1.30% | 1.00% | Adjusted OR (95%CI): | 0.84 |
| 0.95 (0.57-1.57)3 | ||||
| 60-d readmission | 54.60% | 55.30% | Adjusted HR (95%CI): 0.99 (0.94-1.06)4 | 0.99 |
- Citation: Qayed E, Muftah M. Frequency of hospital readmission and care fragmentation in gastroparesis: A nationwide analysis. World J Gastrointest Endosc 2018; 10(9): 200-209
- URL: https://www.wjgnet.com/1948-5190/full/v10/i9/200.htm
- DOI: https://dx.doi.org/10.4253/wjge.v10.i9.200
